Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium -
Department of Cardiovascular Sciences, Katholieke Universiteit Leuven (KU Leuven), Leuven, Belgium -
Minerva Cardiol Angiol. 2021 Apr;69(2):215-221. doi: 10.23736/S2724-5683.20.05184-1. Epub 2020 Apr 23.
Bioresorbable scaffold (BRS) technology provides transient vessel support with drug-delivery capability without the long-term limitations of the permanent metallic drug-eluting stents (DES). Numerous scaffolds have been developed and investigated by device manufacturers, many of which, due to device deficiencies, have fallen by the wayside. This short review will focus on the resorbable magnesium scaffold Magmaris the only metallic bioresorbable scaffold currently available, providing an evaluation of the most up to date clinical data whilst also briefly highlighting learning points regarding the ideal patient and lesion choice and optimal implantation technique.
生物可吸收支架（BRS）技术提供了具有药物输送能力的临时血管支持，而没有永久性金属药物洗脱支架（DES）的长期局限性。许多支架已经被设备制造商开发和研究，其中许多由于设备缺陷而被淘汰。本简短综述将重点介绍可吸收镁支架 Magmaris，这是目前唯一可用的金属生物可吸收支架，评估最新的临床数据，同时还简要介绍理想患者和病变选择以及最佳植入技术方面的学习要点。
